|
({1-[2-(2-fluorophenyl)ethyl]-4-piperidinyl}methyl)methyl(3-thienylmethyl)amine |
|
Salmonella |
Biofilm |
Preclinical (in vivo) |
Woolard KJ, et al. 2022. Eur J Med Chem |
|
Compound 7b (internal name in literature) |
Depiction based on curated SMILES
N
Cl
Cl
CH
3
S
N
|
Salmonella |
Biofilm |
Preclinical (in vivo) |
Woolard KJ, et al. 2022. Eur J Med Chem |
|
Compound 7d (internal name in literature) |
Depiction based on curated SMILES
N
Br
Br
CH
3
S
N
|
Salmonella |
Biofilm |
Preclinical (in vivo) |
Woolard KJ, et al. 2022. Eur J Med Chem |
|
Compound 8j (internal name in literature) |
Depiction based on curated SMILES
CH
3
N
S
N
|
Salmonella |
Biofilm |
Preclinical (in vivo) |
Woolard KJ, et al. 2022. Eur J Med Chem |
|
1-(1-azepanyl)-3-(diphenylamino)-2-propanol |
Depiction based on curated SMILES
OH
N
N
|
Bacillus |
Nutritional/Metabolic factor |
Preclinical (in vitro) |
Fernandes AS, et al. 2021. Front Microbiol |
|
N-benzyl-N-(2-phenylethyl)-1-propyl-4-piperidinamine |
Depiction based on curated SMILES
CH
3
N
N
|
Bacillus |
Nutritional/Metabolic factor |
Preclinical (in vitro) |
Fernandes AS, et al. 2021. Front Microbiol |
|
(5-BROMO-2-METHOXYBENZYL)[2-(3-FLUOROPHENYL)ETHYL]AMINE |
Depiction based on curated SMILES
N
H
F
CH
3
Br
O
|
Bacillus |
Nutritional/Metabolic factor |
Preclinical (in vitro) |
Fernandes AS, et al. 2021. Front Microbiol |
|
(3S)-3-amino-4-(1H-imidazol-5-yl)-1-[4-(2-phenylethynyl)phenyl]butan-2-one |
Depiction based on curated SMILES
NH
2
NH
N
H
O
|
Brucella |
Others |
Preclinical (in vitro) |
Abdo MR, et al. 2011. Org Biomol Chem |
|
(S)-1-[4-(4-Pentylphenylethynyl)phenyl]-3-amino-4-(1H-imidazole-4-yl)-2-butanone |
Depiction based on curated SMILES
H
2
N
HN
N
H
O
CH
3
|
Brucella |
Others |
Preclinical (in vitro) |
Abdo MR, et al. 2011. Org Biomol Chem |
|
3-(2-amino-1H-imidazol-5-yl)-N-(4-phenylbutyl)propanamide;hydrochloride |
Depiction based on curated SMILES
ClH
NH
2
HN
N
O
NH
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Ballard TE, et al. 2008. Chemistry |
|
| | |